| |
| |
|
| Insider
Information: |
Hanson Gregory P |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
136,870 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,629 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
136,870 |
|
|
| Total
Value |
$2,629 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avanir Pharmaceuticals |
AVNR |
VP, CAO & Secretary |
2006-12-13 |
22,563 |
2006-12-13 |
0 |
Premium* |
|
|
Mabvax Therapeutics Holdings Inc |
MBVX |
|
2018-04-02 |
114,307 |
2014-12-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2018-04-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,428) |
114,307 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2018-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,021 |
116,735 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2018-01-16 |
4 |
S |
$0.92 |
$38,523 |
D/D |
(41,873) |
320,013 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2018-01-12 |
4 |
S |
$0.96 |
$10,783 |
D/D |
(11,232) |
361,886 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2018-01-11 |
4 |
S |
$0.98 |
$37,923 |
D/D |
(38,697) |
373,118 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2018-01-10 |
4 |
S |
$0.96 |
$63,888 |
D/D |
(66,550) |
411,815 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2018-01-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
449,159 |
478,365 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2017-05-19 |
4 |
B |
$0.00 |
$7,501 |
D/D |
9,128 |
38,334 |
2.74 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2017-04-12 |
4 |
S |
$2.00 |
$7,770 |
D/D |
(3,885) |
29,206 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2017-04-11 |
4 |
S |
$2.00 |
$400 |
D/D |
(200) |
33,091 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2017-04-10 |
4 |
S |
$2.00 |
$800 |
D/D |
(400) |
33,291 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2017-04-07 |
4 |
S |
$2.01 |
$902 |
D/D |
(450) |
33,691 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2017-04-06 |
4 |
S |
$2.15 |
$1,862 |
D/D |
(867) |
34,141 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2017-04-05 |
4 |
S |
$2.15 |
$3,872 |
D/D |
(1,800) |
35,008 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2017-04-04 |
4 |
S |
$2.25 |
$2,250 |
D/D |
(1,000) |
36,808 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2017-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,064 |
37,808 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2016-08-17 |
4 |
B |
$0.00 |
$0 |
D/D |
3,119 |
16,744 |
0.01 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2016-04-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(58,044) |
100,823 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2016-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
155,867 |
158,867 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
Chief Financial Officer |
• – – |
2014-12-16 |
4 |
B |
$2.50 |
$7,500 |
D/D |
3,000 |
3,000 |
2.74 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
VP, CAO & Secretary |
• – – |
2006-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,400 |
22,563 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
